Cell­tri­on re­ceives Form 483 for trou­bled Ko­re­an site

The FDA late Mon­day re­leased a Form 483 with eight ob­ser­va­tions for Cell­tri­on’s South Ko­re­an site.

The ob­ser­va­tions dur­ing the re-in­spec­tion deal with a lack …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER